Can emicizumab be used to treat patients with severe type 3 VWD?

Current as of 5 August 2026 · added 5 August 2026

Answer: Emicizumab is an emerging off-label treatment for patients with type 3 VWD, with multiple case reports describing favorable control of bleeding.

• Two major studies are ongoing: EmiVWD and Will-EMI (NCT06998524).

Source: Emicizumab for severe von Willebrand disease (VWD): the EmiVWD study